Patents by Inventor Peter Noertersheuser

Peter Noertersheuser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS
    Publication number: 20180110854
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Application
    Filed: June 5, 2017
    Publication date: April 26, 2018
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • Methods for treating juvenile idiopathic arthritis
    Patent number: 9669093
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: June 6, 2017
    Assignee: AbbVie Biotechnology Ltd
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • Methods for Treating Juvenile Idiopathic Arthritis
    Publication number: 20160151488
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Application
    Filed: February 12, 2016
    Publication date: June 2, 2016
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • Methods for treating juvenile idiopathic arthritis
    Patent number: 9284370
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: March 15, 2016
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • Methods for Treating Juvenile Idiopathic Arthritis
    Publication number: 20160060336
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Application
    Filed: April 6, 2015
    Publication date: March 3, 2016
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • Methods for treating juvenile idiopathic arthritis by inhibition of TNF?
    Patent number: 8999337
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: April 7, 2015
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • HUMAN ANTIBODIES THAT BIND THE P40 SUBUNIT OF HUMAN IL-12/IL-23 AND USES THEREFOR
    Publication number: 20140093516
    Abstract: The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 3, 2014
    Inventors: Matthew Hruska, Susan K. Paulson, Peter Noertersheuser, Sven Mensing, Walid Awni
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20140079714
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 11, 2013
    Publication date: March 20, 2014
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Thomas C. Harris, Martin Kaul, Parvez M. Mulani, Peter A. Noertersheuser, Martin M. Okun
  • Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
    Patent number: 8557239
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: October 15, 2013
    Assignees: AbbVie Inc., AbbVie Deutschland GmbH & Co. KG
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Tom C. Harris, Martin Kaul, Parvez M. Mulani, Peter Noertersheuser, Martin M. Okun
  • HUMAN ANTIBODIES THAT BIND THE P40 SUBUNIT OF HUMAN IL-12/IL-23 AND USES THEREFOR
    Publication number: 20120225080
    Abstract: The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: January 13, 2012
    Publication date: September 6, 2012
    Applicant: Abbott Laboratories
    Inventors: Matthew W. Hruska, Susan K. Paulson, Walid Awni, Peter Noertersheuser, Sven Mensing
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20110206680
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 25, 2011
    Applicants: ABBOTT LABORATORIES, ABBOTT GMBH & CO., KG
    Inventors: JOAQUIN MARIO VALDES, ELLIOT K. CHARTASH, WILLIAM T. BARCHUK, SUSAN K. PAULSON, KENNETH B. GORDON, WALID M. AWNI, YANJUN BAO, WILLIAM G. GLASS, YIHUA GU, TOM C. HARRIS, MARTIN KAUL, PARVEZ M. MULANI, PETER NOERTERSHEUSER, MARTIN M. OKUM
  • PREDICTING LONG-TERM EFFICACY OF A COMPOUND IN THE TREATMENT OF PSORIASIS
    Publication number: 20090271164
    Abstract: The invention provides a method for predicting the efficacy of a compound for treating psoriasis based on a pharmacokinetic/pharmacodynamic model.
    Type: Application
    Filed: December 31, 2008
    Publication date: October 29, 2009
    Inventors: Joanna Z. Peng, Peter A. Noertersheuser
  • Methods for treating juvenile idiopathic arthritis
    Publication number: 20090258018
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Application
    Filed: June 10, 2008
    Publication date: October 15, 2009
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser
  • METHODS FOR ADMINISTERING LEVOSIMENDAN
    Publication number: 20080070917
    Abstract: The invention relates to a method of administering an inotropic agent (such as, but not limited to, a levosimendan compound) or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders.
    Type: Application
    Filed: April 27, 2007
    Publication date: March 20, 2008
    Inventors: Roopal Thakkar, Leticia Delgado-Herrera, Rajendra Pradhan, Peter Noertersheuser, Walid Awni, Wenhui Zhang
  • Method for establishing a dosage plan for thrombin inhibitors
    Patent number: 6489289
    Abstract: After a standard dose of a hirudin or an oral thrombin inhibitor is given to a recipient, the concentration of the hirudin or oral thrombin inhibitor in the blood of the recipient is determined using the ecarin clogging time test. From the ratio of the dose given to the recipient to the measured ecarin clotting time, a dosage plan-i.e., the dosage of the hirudin or oral thrombin inhibitor to be given thereafter-is established. For this purpose a pharmacokinetics/pharmacodynamics model is employed using a statistics program. A further dose of the hirudin or oral thrombin inhibitor is then administered to the recipient in accordance with the established dosage plan.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: December 3, 2002
    Assignee: Abbott Laboratories
    Inventors: Peter Nörtersheuser, Siegfried Kreis